Rapid CLIP Dissociation from MHC II Promotes an Unusual Antigen Presentation Pathway in Autoimmunity

Total Page:16

File Type:pdf, Size:1020Kb

Load more

Published Online: 5 September, 2018 | Supp Info: http://doi.org/10.1084/jem.20180300 Downloaded from jem.rupress.org on September 5, 2018 ARTICLE Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity Yoshinaga Ito1,2, Orr Ashenberg3, Jason Pyrdol1, Adrienne M. Luoma1,2, Orit Rozenblatt‑Rosen3, Matan Hofree3, Elena Christian3, Lucas Ferrari de Andrade1,2, Rong En Tay1,2, Luc Teyton4, Aviv Regev3, Stephanie K. Dougan1,2, and Kai W. Wucherpfennig1,2 A number of autoimmunity-associated MHC class II proteins interact only weakly with the invariant chain–derived class II– associated invariant chain peptide (CLIP). CLIP dissociates rapidly from I-Ag7 even in the absence of DM, and this property is related to the type 1 diabetes–associated β57 polymorphism. We generated knock-in non-obese diabetic (NOD) mice with a single amino acid change in the CLIP segment of the invariant chain in order to moderately slow CLIP dissociation from I-Ag7. These knock-in mice had a significantly reduced incidence of spontaneous type 1 diabetes and diminished islet infiltration by CD4 T cells, in particular T cells specific for fusion peptides generated by covalent linkage of proteolytic fragments within β cell secretory granules. Rapid CLIP dissociation enhanced the presentation of such extracellular peptides, thus bypassing the conventional MHC class II antigen-processing pathway. Autoimmunity-associated MHC class II polymorphisms therefore not only modify binding of self-peptides, but also alter the biochemistry of peptide acquisition. Introduction The MHC locus plays a central role in susceptibility to many the P9 pocket (Brown et al., 1993; Scott et al., 1998). In contrast, human autoimmune diseases, including type 1 diabetes (T1D; the absence of a negative charge at β57 of DQ8, DQ2, and I-Ag7 Davies et al., 1994; Hu et al., 2015). In many of these diseases, results in a P9 pocket with a positive charge that has a strong the strongest association is observed with particular alleles of preference for negatively charged peptide side chains (Corper et MHC class II (MHC II) genes, providing strong evidence for a al., 2000; Lee et al., 2001; Kim et al., 2004). The major hypothesis critical role of antigen presentation to CD4 T cells. T1D is an ex- for the role of the β57 polymorphism in the pathogenesis of T1D cellent example for this general principle: susceptibility is most has been that it enables binding of pathogenic peptides (Todd et closely associated with certain alleles of the DQB1 gene, in par- al., 1987; Quartey-Papafio et al., 1995). As we will discuss here, ticular those encoding HLA-DQ8 (DQB1*03:02) and HLA-DQ2 the β57 polymorphism also has an impact on the affinity of the (DQB1*02:01; Todd et al., 1987; Concannon et al., 2009). The invariant chain–derived class II–associated invariant chain pep- DQB1*03:02 and DQB1*02:01 alleles share an important polymor- tide (CLIP), and may therefore also modulate the biochemistry phism: position 57 of the β chain encodes a nonaspartic residue of peptide binding. in T1D-associated alleles, but aspartic acid in most other DQB1 MHC II proteins associate with the invariant chain in the ER, alleles. This polymorphism is also relevant for the spontaneous and this complex is targeted to the endosomal compartment, mouse model of T1D in non-obese diabetic (NOD) mice because where the invariant chain is degraded, leaving CLIP in the bind- β57 of I-Ag7 is also a nonaspartic acid residue (serine; Acha-Orbea ing groove (Avva and Cresswell, 1994; Denzin and Cresswell, and McDevitt, 1987). Crystal structures of DQ8, DQ2, and I-Ag7 1995). Textbooks state that H2-DM (abbreviated as DM) induces have demonstrated that this polymorphic position has a major CLIP dissociation and thereby enables binding of peptides gener- impact on the charge of the P9 pocket of the peptide binding ated by proteolysis of exogenous antigens. However, the affinity groove (Corper et al., 2000; Lee et al., 2001; Kim et al., 2004). An of CLIP differs by four orders of magnitude among MHC II pro- aspartic acid at β57 forms a salt bridge with arginine 76 of the DQ teins because many polymorphic residues shape the specificity or I-A α chains, allowing binding of hydrophobic amino acids in of the peptide binding groove (Sette et al., 1995). We previously 1Department of Cancer Immunology and Virology, Dana‑Farber Cancer Institute, Boston, MA; 2Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA; 3Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA; 4Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA. Correspondence to Kai W. Wucherpfennig: kai _wucherpfennig@ dfci .harvard .edu; Stephanie K. Dougan: stephanie _dougan@ dfci .harvard .edu. © 2018 Ito et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http:// www .rupress .org/ terms/ ). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https:// creativecommons .org/ licenses/ by ‑nc ‑sa/ 4 .0/ ). Rockefeller University Press https://doi.org/10.1084/jem.20180300 1 J. Exp. Med. 2018 demonstrated that the diabetes-associated I-Ag7 protein binds Results CLIP with very low affinity, allowing CLIP to rapidly dissociate Knock-in mice with a single amino acid substitution of CLIP in a DM-independent manner at an acidic pH characteristic for have a reduced incidence of T1D the endosomal peptide loading compartment (Hausmann et al., We generated knock-in mice with a single amino acid substitu- 1999). The low affinity of CLIP for I-Ag7 is related to the β57 poly- tion of the P9 anchor of CLIP. The methionine to alanine (ATG to morphism: the hydrophobic P9 anchor of CLIP (methionine) is GCT) substitution was designed to result in a moderate increase a poor fit for the positively charged P9 pocket, and substitution in CLIP affinity for I-Ag7 (Fig. 1, A and B; Hausmann et al., 1999). of the P9 anchor of CLIP to alanine or aspartic acid increases the Peptide binding studies demonstrated very little to no binding affinity of CLIP for I-Ag7. A number of MHC II proteins associated of WT CLIP to I-Ag7 at pH 5.2, which corresponds to the pH of the with human autoimmune diseases have been shown to have a endosomal peptide loading compartment. In contrast, binding low affinity for CLIP (Reed et al., 1997; Patil et al., 2001) . CLIP was clearly detected for I-Ag7 with a serine to aspartic acid mu- was also shown to bind with rather low affinity to HLA-DQ8, tation at position β57 (β S57D), indicating that the disease-asso- and peptide elution studies showed that HLA-DQ2 binds CLIP ciated β57 polymorphism impacts CLIP binding. A single amino in an unusual alternative register with relatively low affinity acid substitution at the P9 position of CLIP from methionine to (Fallang et al., 2008; Wiesner et al., 2008). Both HLA-DQ2 and alanine (M98A) resulted in a moderate increase of CLIP binding HLA-DQ8 also interact only weakly with DM (Fallang et al., 2008; to I-Ag7, while a high-affinity positive control peptide derived Zhou et al., 2016). Rapid CLIP dissociation may enable binding from albumin (Alb 560–574) showed strong binding to I-Ag7, as of peptides in compartments that lack DM and may also favor expected (Fig. 1 C). These results were consistent with previous g7 presentation of low-affinity peptides that are not edited by DM. peptide binding studies with I-A that demonstrated an IC50 of This hypothesis is consistent with data demonstrating that the >125 µM for WT CLIP, 15 µM for CLIP M98A, and 0.5 µM for CLIP bound repertoire of peptides has a lower average half-life for M98D at an acidic pH. Previous work had also demonstrated that I-Ag7 compared with other I-A proteins (Carrasco-Marin et al., CLIP binds to I-Ag7 at neutral pH, which is relevant for assembly 1996; Kropshofer et al., 1996). of I-Ag7 with invariant chain in the ER (Hausmann et al., 1999). These alterations in the biochemistry of peptide binding by The CLIP M98A mutation was introduced directly into the ge- I-Ag7 may have a significant impact on the pathogenesis of T1D nome of WT NOD mice by micro-injection of fertilized oocytes in NOD mice. There is increasing evidence for the importance with Cas9 mRNA, a guide RNA (gRNA) targeting the invariant of unique types of antigens that are released as proteolytic frag- chain gene (Cd74) and a single-stranded DNA oligonucleotide for ments by pancreatic β cells. One of the major identified antigens homology-directed repair of the double-strand break introduced is the insulin B9-23 peptide, which binds in at least two registers by Cas9. A small molecule inhibitor of nonhomologous end join- to I-Ag7 (Daniel et al., 1995; Mohan et al., 2011). Proinsulin under- ing was also coinjected, which was previously shown to reduce goes proteolytic processing in secretory granules of β cells, and off-target lesions and enhance the efficiency of homology-di- proteolytic fragments containing the insulin B9-23 epitope are rected repair (Maruyama et al., 2015). Furthermore, we used a present in these secretory granules (Mohan et al., 2010). Indeed, gRNA with a minimal length of 17 bases, which was shown to CD4 T cells specific for the insulin B12-20 peptide (a lower-affin- greatly diminish the frequency of off-target lesions (Fu et al., ity register) are only activated when APCs are incubated with the 2014).
Recommended publications
  • Selection in the Thymus Stromal Cell Type in Positive and Negative

    Selection in the Thymus Stromal Cell Type in Positive and Negative

    Differential Effects of Peptide Diversity and Stromal Cell Type in Positive and Negative Selection in the Thymus This information is current as Graham Anderson, Katharine M. Partington and Eric J. of September 29, 2021. Jenkinson J Immunol 1998; 161:6599-6603; ; http://www.jimmunol.org/content/161/12/6599 Downloaded from References This article cites 31 articles, 9 of which you can access for free at: http://www.jimmunol.org/content/161/12/6599.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 29, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Differential Effects of Peptide Diversity and Stromal Cell Type in Positive and Negative Selection in the Thymus1 Graham Anderson,2 Katharine M. Partington, and Eric J. Jenkinson Thymocyte positive selection results in maturation to the single-positive stage, while negative selection results in death by apo- ptosis. Although kinetic analyses indicate only 3–5% of CD4181 cells reach the single-positive stage, the balance of positive and negative selection and the nature and quantity of cells mediating maximal negative selection are uncertain.
  • Class II Allotypes Promiscuous Binding of Invariant Chain to MHC

    Class II Allotypes Promiscuous Binding of Invariant Chain to MHC

    Identification of a Sequence That Mediates Promiscuous Binding of Invariant Chain to MHC Class II Allotypes1 Ina M. Siebenkotten, Cornelia Carstens, and Norbert Koch2 The invariant chain (Ii) shows promiscuous binding to a great variety of MHC class II allotypes. In contrast, the affinities of the Ii-derived fragments, class II-associated Ii peptides, show large differences in binding to class II allotypes. The promiscuous association of Ii to all class II polypeptides therefore requires an additional contact site to stabilize the interaction to the poly- morphic class II cleft. We constructed recombinant molecules containing the class II binding site of Ii (CBS) and tested their association with HLA-DR dimers. The CBS fused to the transferrin receptor mediates binding of transferrin receptor-CBS to class II dimers. Within the CBS, deletion of a sequence N-terminal to the groove-binding motif abolished binding of Ii to DR. A promiscuous class II binding site was identified by reinsertion of the N-terminal residues, amino acids 81–87, of Ii into an Ii mutant that lacks the groove-binding segment. DR allotype-dependent association of Ii was achieved by insertion of antigenic sequences. The promiscuous association, in contrast to the class II allotype-dependent binding of Ii, is important to prevent interaction of class II dimers to nascent polypeptides in the endoplasmic reticulum. The Journal of Immunology, 1998, 160: 3355–3362. he first indication that the invariant chain (Ii)3 plays a groove, whereas the N terminus of the Ii fragment is disordered in functional role in Ag processing was obtained with Ii- the crystal (21).
  • Endosomal/Lysosomal Compartments Receptor and Modulates Its

    Endosomal/Lysosomal Compartments Receptor and Modulates Its

    The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fc γ Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments This information is current as of October 2, 2021. Lilin Ye, Xindong Liu, Subrat N. Rout, Zili Li, Yongqi Yan, Li Lu, Tirumalai Kamala, Navreet K. Nanda, Wenxia Song, Siba K. Samal and Xiaoping Zhu J Immunol 2008; 181:2572-2585; ; doi: 10.4049/jimmunol.181.4.2572 Downloaded from http://www.jimmunol.org/content/181/4/2572 References This article cites 68 articles, 35 of which you can access for free at: http://www.jimmunol.org/content/181/4/2572.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists by guest on October 2, 2021 • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2008 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The MHC Class II-Associated Invariant Chain Interacts with the Neonatal Fc␥ Receptor and Modulates Its Trafficking to Endosomal/Lysosomal Compartments1 Lilin Ye,*§ Xindong Liu,*§ Subrat N.
  • Bidirectional Binding of Invariant Chain Peptides to an MHC Class II Molecule

    Bidirectional Binding of Invariant Chain Peptides to an MHC Class II Molecule

    Bidirectional binding of invariant chain peptides to an MHC class II molecule Sebastian Günthera,b,1, Andreas Schlundta,1, Jana Stichta, Yvette Roskeb, Udo Heinemannb, Karl-Heinz Wiesmüllerc, Günther Jungc, Kirsten Falkb, Olaf Rötzschkeb,d, and Christian Freunda,2 aLeibniz-Institute for Molecular Pharmacology and Freie Universität Berlin, 13125 Berlin, Germany; bMax-Delbrück-Center for Molecular Medicine, 13125 Berlin, Germany; cEMC Microcollections GmbH, D-72070 Tübingen, Germany; and dSingapore Immunology Network, Agency of Science, Technology and Research, Singapore 138648 Edited* by Emil R. Unanue, Washington University, St. Louis, MO, and approved November 2, 2010 (received for review September 30, 2010) T-cell recognition of peptides bound to MHC class II (MHCII) Here we determined the crystal structures of the human MHCII molecules is a central event in cell-mediated adaptive immunity. molecule HLA-DR1 in complex with two CLIP length variants The current paradigm holds that prebound class II-associated in- and observed a unique bidirectional binding mode. NMR analyses variant chain peptides (CLIP) and all subsequent antigens maintain by chemical shift mapping and spin label-induced relaxation en- a canonical orientation in the MHCII binding groove. Here we hancement of the uncatalyzed and HLA-DM edited reactions il- provide evidence for MHCII-bound CLIP inversion. NMR spectroscopy lustrate the dynamic reorientation of the complex in solution. demonstrates that the interconversion from the canonical to the Surface charge distributions differ largely for the two MHC-CLIP inverse alignment is a dynamic process, and X-ray crystallography variants and result in T-cell epitopes with inverted polarity. shows that conserved MHC residues form a hydrogen bond network with the peptide backbone in both orientations.
  • Evolution of Male Pregnancy Associated with Remodeling of Canonical Vertebrate Immunity in Seahorses and Pipefishes

    Evolution of Male Pregnancy Associated with Remodeling of Canonical Vertebrate Immunity in Seahorses and Pipefishes

    Evolution of male pregnancy associated with remodeling of canonical vertebrate immunity in seahorses and pipefishes Olivia Rotha,1, Monica Hongrø Solbakkenb, Ole Kristian Tørresenb, Till Bayera, Michael Matschinerb,c, Helle Tessand Baalsrudb, Siv Nam Khang Hoffb, Marine Servane Ono Brieucb, David Haasea, Reinhold Haneld, Thorsten B. H. Reuscha,2, and Sissel Jentoftb,2 aMarine Evolutionary Ecology, GEOMAR Helmholtz Centre for Ocean Research Kiel, D-24105 Kiel, Germany; bCentre for Ecological and Evolutionary Synthesis, Department of Biosciences, University of Oslo, NO-0371 Oslo, Norway; cDepartment of Palaeontology and Museum, University of Zurich, CH-8006 Zürich, Switzerland; and dThünen Institute of Fisheries Ecology, D-27572 Bremerhaven, Germany Edited by Günter P. Wagner, Yale University, New Haven, CT, and approved March 13, 2020 (received for review September 18, 2019) A fundamental problem for the evolution of pregnancy, the most class I and II genes (7–9) plays a key role for self/nonself-recognition. specialized form of parental investment among vertebrates, is the While in mammals an initial inflammation seems crucial for embryo rejection of the nonself-embryo. Mammals achieve immunological implantation (10), during pregnancy mammals prevent an immuno- tolerance by down-regulating both major histocompatibility com- logical rejection of the embryo with tissue layers of specialized fetal plex pathways (MHC I and II). Although pregnancy has evolved cells, the trophoblasts (11–13). Trophoblasts do not express MHC II multiple times independently among vertebrates, knowledge of (14–16) and thus prevent antigen presentation to maternal T-helper associated immune system adjustments is restricted to mammals. (Th) cells (17), which otherwise would trigger an immune response All of them (except monotremata) display full internal pregnancy, against nonself.
  • Binding of Major Histocompatibility Complex Class 1I to the Invariant

    Binding of Major Histocompatibility Complex Class 1I to the Invariant

    Binding of Major Histocompatibility Complex Class 1I to the Invariant Chain-derived Peptide, CLIP, Is Regulated by Allelic Polymorphism in Class 1I By Alessandro Sette,* Scott Southwood,* Jim Miller, and Ettore Appella$ From the "Department of Immunology, Cytel, San Diego, CA 92121; the *Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois 60637-1432; and SNational Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892 Summary Major histocompatibility complex class II-associated invariant chain (Ii) provides several important functions that regulate class II expression and function. One of these is the ability to inhibit class II peptide loading early in biosynthesis. This allows for efficient class II folding and egress from the endoplasmic reticulum, and protects the class II peptide binding site from loading with peptides before entry into endosomal compartments. The ability of Ii to interact with class II and interfere with peptide loading has been mapped to Ii exon 3, which encodes amino acids 82-107. This same region of Ii has been described as a nested set of class II-associated Ii peptides (CLIPs) that are transiently associated with class II in normal cells and accumulate in human histocompatibility leukocyte antigen-DM-negative cell lines. Currently it is not clear how CLIP and the CLIP region of Ii blocks peptide binding. CLIP may bind directly to the class II peptide binding site, or may bind elsewhere on class II and modulate class II peptide binding a11osterically. In this report, we show that CLIP can interact with many different murine and human class II molecules, but that the affinity of this interaction is controlled by polymorphic residues in the class II chains.
  • Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome

    Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome

    [CANCER RESEARCH 64, 5546–5550, August 15, 2004] Advances in Brief Class II-Associated Invariant Chain Peptide Expression on Myeloid Leukemic Blasts Predicts Poor Clinical Outcome Martine E. D. Chamuleau,1 Yuri Souwer,3,4,5 S. Marieke van Ham,4 Adri Zevenbergen,1 Theresia M. Westers,1 Johannes Berkhof,2 Chris J. L. M. Meijer,3 Arjan A. van de Loosdrecht,1 and Gert J. Ossenkoppele1 Departments of 1Hematology, 2Clinical Epidemiology and Biostatistics, and 3Pathology, VU University Medical Center, Amsterdam, the Netherlands; 4Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; 5Department of Immunopathology, Sanquin Research at Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam, the Netherlands Abstract CLIP correlates with a high DO:DM ratio and can be viewed as an indicator for low effectiveness of antigen presentation (8). ؉ Effective antitumor responses need the activation of CD4 T cells. In MHC class II negative tumors, the activation of CD4ϩ T cells MHC class II antigen presentation requires the release of class II-associ- relies on presentation of tumor antigens by professional antigen- ated invariant chain peptide (CLIP) from the antigen-binding site. In presenting cells (APCs). MHC class II transfection studies in mice antigen-presenting cells, human leukocyte antigen DM (HLA-DM; abbre- viated DM in this article) catalyzes CLIP dissociation. In B cells, HLA-DO have shown that, upon expression of MHC class II molecules, tumor ϩ (DO) down-modulates DM function. Cell surface CLIP:HLA-DR (DR) cells can present their tumor antigens directly to CD4 T cells, thus ratio correlates to DO:DM ratio and the efficacy of antigen presentation.
  • Ancient Features of the MHC Class II Presentation Pathway, and a Model for the Possible Origin of MHC Molecules

    Ancient Features of the MHC Class II Presentation Pathway, and a Model for the Possible Origin of MHC Molecules

    Immunogenetics (2019) 71:233–249 https://doi.org/10.1007/s00251-018-1090-2 REVIEW Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules Johannes M. Dijkstra1 & Takuya Yamaguchi2 Received: 16 August 2018 /Accepted: 6 October 2018 /Published online: 30 October 2018 # Springer-Verlag GmbH Germany, part of Springer Nature 2018 Abstract Major histocompatibility complex (MHC) molecules are only found in jawed vertebrates and not in more primitive species. MHC class II type structures likely represent the ancestral structure of MHC molecules. Efficient MHC class II transport to endosomal compartments depends on association with a specialized chaperone, the MHC class II invariant chain (aliases Ii or CD74). The present study identifies conserved motifs in the CLIP region of CD74 molecules, used for binding in the MHC class II binding groove, throughout jawed vertebrates. Peculiarly, in CD74a molecules of Ostariophysi, a fish clade including for example Mexican tetra and zebrafish, the CLIP region has duplicated. In mammals, in endosomal compartments, the peptide-free form of classical MHC class II is stabilized by binding to nonclassical MHC class II BDM,^ a process that participates in Bpeptide editing^ (selection for high affinity peptides). Hitherto, DM-lineage genes had only been reported from the level of amphibians, but the present study reveals the existence of DMA and DMB genes in lungfish. This is the first study which details how classical and DM lineage molecules have distinguishing glycine-rich motifs in their transmembrane regions. In addition, based on extant MHC class II structures and functions, the present study proposes a model for early MHC evolution, in which, in an ancestral jawed vertebrate, the ancestral MHC molecule derived from a heavy-chain-only antibody type molecule that cycled between the cell surface and endosomal compartments.
  • Assembly, Maturation, and Function Mutant HLA-DM Molecule

    Aberrant Intermolecular Disulfide Bonding in a Mutant HLA-DM Molecule: Implications for Assembly, Maturation, and Function This information is current as Robert Busch, Robert C. Doebele, Emily von Scheven, Jimothy of September 28, 2021. Fahrni and Elizabeth D. Mellins J Immunol 1998; 160:734-743; ; http://www.jimmunol.org/content/160/2/734 Downloaded from References This article cites 51 articles, 17 of which you can access for free at: http://www.jimmunol.org/content/160/2/734.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on September 28, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 1998 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Aberrant Intermolecular Disulfide Bonding in a Mutant HLA-DM Molecule: Implications for Assembly, Maturation, and Function1 Robert Busch,2* Robert C. Doebele,† Emily von Scheven,‡ Jimothy Fahrni,* and Elizabeth D. Mellins* HLA-DM (abbreviated DM) is an MHC-encoded glycoprotein that catalyzes the selective release of peptides, including class II-associated invariant chain peptides, from MHC class II molecules.
  • RA0066-C.5-IFU-RUO CD74 (B-Cell Marker); Clone CLIP/813

    Instructions For Use RA00 66 -C.5 -IFU -RUO Revision: 1 Rev. Date: Oct. 3, 2014 Page 1 of 2 P.O. Box 3286 - Logan, Utah 84323, U.S.A. - Tel. (800) 729-8350 – Tel. (435) 755-9848 - Fax (435) 755-0015 - www.scytek.com CD74 (B-Cell Marker); Clone CLIP/813 (Concentrate) Availability/Contents: Item # Volume RA0066-C.5 0.5 ml Description: Species: Mouse Immunogen: Recombinant human CD74 protein Clone: CLIP/813 Isotype: IgG1, kappa Entrez Gene ID: 972 (Human) Hu Chromosome Loc.: 5q33.1 Synonyms: CLIP, DHLAG, Gamma chain of class II antigens, HLA class II histocompatibility antigen gamma chain, HLA-DR antigens-associated invariant chain, HLADR-gamma (HLADG), Ia antigen-associated invariant chain, la-gamma, Major histocompatibility complex class II invariant chain, MHC HLA-DR gamma chain Mol. Weight of Antigen: 33-41kDa Format: 200µg/ml of Ab purified from Bioreactor Concentrate by Protein A/G. Prepared in 10mM PBS with 0.05% BSA & 0.05% azide. Specificity: This monoclonal antibody recognizes a protein of ~35kDa, identified as CD74. Background: CD74 is a type II transmembrane protein which binds to the peptide binding groove of newly synthesized MHC class II alpha/beta heterodimers and prevents their premature association with endogenous polypeptides. CD74 is expressed primarily by antigen presenting cells, such as B-lymphocytes (from before the pre-B cell stage to before the plasma cell stage), macrophages, monocytes, and many epithelial cells. Anti-CD74 stains predominantly germinal center lymphocytes and B-cell lymphomas, but rarely T-cell lymphomas. Anti-CD74 has been shown to be useful in differentiating atypical fibroxanthoma (-) from malignant fibrous histiocytoma (+).
  • Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression

    Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression

    Hindawi Publishing Corporation Journal of Nutrition and Metabolism Volume 2016, Article ID 4280876, 8 pages http://dx.doi.org/10.1155/2016/4280876 Research Article Vitamin D3 Suppresses Class II Invariant Chain Peptide Expression on Activated B-Lymphocytes: A Plausible Mechanism for Downregulation of Acute Inflammatory Conditions Omar K. Danner,1 Leslie R. Matthews,1 Sharon Francis,1 Veena N. Rao,1 Cassie P. Harvey,2 Richard P. Tobin,2 Ken L. Wilson,3 Ernest Alema-Mensah,1 M. Karen Newell Rogers,2 and Ed W. Childs1 1 Morehouse School of Medicine, Atlanta, GA, USA 2Texas A&M School of Medicine, Temple, TX, USA 3Michigan State University College of Human Medicine, Flint, MI, USA Correspondence should be addressed to Omar K. Danner; [email protected] Received 24 December 2015; Revised 17 March 2016; Accepted 18 April 2016 Academic Editor: Azeddine Ibrahimi Copyright © 2016 Omar K. Danner et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Class II invariant chain peptide (CLIP) expression has been demonstrated to play a pivotal role in the regulation of B cell function after nonspecific polyclonal expansion. Several studies have shown vitamin D3 helps regulate the immune response. We hypothesized that activated vitamin D3 suppresses CLIP expression on activated B-cells after nonspecific activation or priming of C57BL/6 mice with CpG. This study showed activated vitamin D3 actively reduced CLIP expression and decreased the number + of CLIP B-lymphocytes in a dose and formulation dependent fashion.
  • Specific Treatment of Autoimmunity with Recombinant Invariant Chains in Which CLIP Is Replaced by Self-Epitopes

    Specific Treatment of Autoimmunity with Recombinant Invariant Chains in Which CLIP Is Replaced by Self-Epitopes

    Specific treatment of autoimmunity with recombinant invariant chains in which CLIP is replaced by self-epitopes Felix Bischof*†‡§, Wolfgang Wienhold†‡, Christoph Wirblich†, Georg Malcherek†, Olayinka Zevering*, Ada M. Kruisbeek*, and Arthur Melms† *Division of Immunology, The Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands; and †Department of Neurology, University of Tu¨bingen, 72076 Tu¨bingen, Germany Edited by Michael Sela, Weizmann Institute of Science, Rehovot, Israel, and approved August 23, 2001 (received for review May 4, 2001) The invariant chain (Ii) binds to newly synthesized MHC class II antigen-specific tolerance and preventing EAE. Importantly, i.v. molecules with the CLIP region of Ii occupying the peptide-binding injection of Ii-MBP84–96 or Ii-PLP139–151 after disease induc- groove. Here we demonstrate that recombinant Ii proteins with tion completely suppressed EAE, demonstrating the qualities of the CLIP region replaced by antigenic self-epitopes are highly recombinant Ii proteins as potent antigen delivery systems for efficient in activating and silencing specific T cells in vitro and in the treatment of autoimmunity. vivo. The Ii proteins require endogenous processing by antigen- presenting cells for efficient T cell activation. An Ii protein encom- Materials and Methods passing the epitope myelin basic protein amino acids 84–96 (Ii- Mice. SJL mice were bred under specific pathogen-free condi- MBP84–96) induced the model autoimmune disease experimental tions at the Netherlands Cancer Institute. In all experiments, 8- allergic encephalomyelitis (EAE) with a higher severity and earlier to 12-week-old female mice were used according to approved onset than the peptide. When applied in a tolerogenic manner, protocols.